Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 8/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.42 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19165108 | 0.98 | CYP2A6 (0.45) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL12445155 | 0.98 | CYP2A6 (0.45) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL13082012 | 0.88 | CYP2A6 (0.43) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL14002713 | 0.88 | ESR2 (0.44) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL10820285 | 0.86 | CYP2A6 (0.42) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL498678 | 0.86 | DPP4 (0.51) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL698354 | 0.86 | DPP4 (0.51) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL92955 | 0.86 | CYP2A6 (0.42) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL92960 | 0.86 | CYP2A6 (0.42) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 | |
| SCHEMBL18027618 | 0.86 | CYP2A6 (0.42) | CYP2A6CYP3A4CYP2C19CYP2B6CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388836-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL TERTHIOPHENE COMPOUND OR THIOPHENE OLIGOMER COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-20260047337-A1 | MANAGING 2D/3D HETEROSTRUCTURE ENERGY LANDSCAPE VIA PI-CONJUGATED ORGANIC CATIONS FOR EFFICIENT PEROVSKITE SOLAR CELLS | PURDUE RESEARCH FOUNDATION | 2026-02-12 | — | — | US | disclosed |
| US-12435100-B2 | Perovskite solar cells | PURDUE RESEARCH FOUNDATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-12202954-B2 | Rubber composition and crosslinked rubber molded product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-01-21 | — | — | US | disclosed |
| US-20240172555-A1 | MANAGING 2D/3D HETEROSTRUCTURE ENERGY LANDSCAPE VIA PI-CONJUGATED ORGANIC CATIONS FOR EFFICIENT PEROVSKITE SOLAR CELLS | UNITED STATES DEPARTMENT OF ENERGY | 2024-05-23 | — | — | US | disclosed |
| US-11800784-B2 | Two-dimensional halide perovskite materials | PURDUE RESEARCH FOUNDATION (US) | 2023-10-24 | — | — | US | disclosed |
| US-11800784-B2 | Two-dimensional halide perovskite materials | PURDUE RESEARCH FOUNDATION (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230114853-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER MOLDED PRODUCT | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11605813-B2 | Silicon-based energy storage devices with functional terthiophene compound or thiophene oligomer compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-03-14 | — | — | US | disclosed |
| US-20220246865-A1 | PEROVSKITE SOLAR CELLS | PURDUE RESEARCH FOUNDATION (US) | 2022-08-04 | — | — | US | disclosed |
| US-20020156062-A1 | Drug delivery system for hydrophobic drugs | BAUSCH HEALTH COMPANIES INC. (CA) | 2002-10-24 | — | — | US | disclosed |
| US-20020155089-A1 | Drug delivery systems for photodynamic therapy | UNIVERSITY OF BRITISH COLUMBIA, THE (CA) | 2002-10-24 | — | — | US | disclosed |
| WO-2002062386-A2 | PHOTODYNAMIC THERAPY OF OCCULT CHOROIDAL NEOVASCULARIZATION LINKED TO AGE-RELATED MACULAR DEGENERATION | QLT INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| EP-1229937-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT Inc. (CA) | 2002-08-14 | — | — | EP | disclosed |
| US-20020061330-A1 | Supports for photosensitizer formulations | BRITISH COLUMBIA, THE UNIVERSITY OF (CA) | 2002-05-23 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001085212-A2 | DRUG DELIVERY SYSTEMS FOR PHOTODYNAMIC THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156062-A1 | Drug delivery system for hydrophobic drugs | LIPA, MLEC, ABCG2 | CYP2A6 284/4885CYP3A4 809/4885CYP2C19 965/4885 |
| US-20020155089-A1 | Drug delivery systems for photodynamic therapy | PIN1, PPOX, DHFR | CYP2A6 389/4885CYP3A4 314/4885CYP2C19 227/4885 |
| US-20020061330-A1 | Supports for photosensitizer formulations | PPOX, PPIF, SDHA | CYP2A6 1221/4885CYP3A4 1095/4885CYP2C19 588/4885 |
| US-20260047337-A1 | MANAGING 2D/3D HETEROSTRUCTURE ENERGY LANDSCAPE VIA PI-CONJUGATED ORGANIC CATIONS FOR EFFICIENT PEROVSKITE SOLAR CELLS | SLC9A3, ITGB4, SLC9A2 | CYP2A6 4305/4885CYP3A4 1225/4885CYP2C19 1745/4885 |
| US-20220246865-A1 | PEROVSKITE SOLAR CELLS | BCL3, MCL1, ANXA3 | CYP2A6 4500/4885CYP3A4 4466/4885CYP2C19 4453/4885 |
| US-12435100-B2 | Perovskite solar cells | BCL3, MCL1, ANXA3 | CYP2A6 4500/4885CYP3A4 4466/4885CYP2C19 4453/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | CYP2A6 2844/4885CYP3A4 3319/4885CYP2C19 4077/4885 |
| US-11800784-B2 | Two-dimensional halide perovskite materials | EYA2, BRAP, EYA3 | CYP2A6 4197/4885CYP3A4 4198/4885CYP2C19 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.